Alphabet Inc.
13F Reported Value
ⓘ$4.0B
Holdings
26
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Alphabet Inc. disclosed 26 positions worth $4.0B in its Form 13F-HR for Q1 2026, led by $CME (CME GROUP INC.) at 25.6% of the equity portfolio, followed by $PL and $ASTS. During the quarter the fund opened 3 new positions and exited 6 — including a new stake in $CME and a full exit from $DXCM. The portfolio is most concentrated in Technology (40.4% of disclosed assets). All figures are sourced directly from Alphabet Inc.’s Form 13F-HR filing with the SEC under CIK 1652044.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 74.5#157
Quality
$1.0B3,484,020 sh - 42.2#1,857
Quality
$985.2M35,248,893 sh - 29.6#2,395
Quality
$741.1M8,943,486 sh - —
Quality
$320.2M3,292,525 sh - —
Quality
$296.6M1,960,784 sh - 55.5
Quality
$130.1M16,206,643 sh - 67.7
Quality
$78.1M7,034,337 sh - 38.2
Quality
$70.1M1,551,102 sh - —
Quality
$66.7M3,125,000 sh - 54.1
Quality
$59.0M2,724,712 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 CME GROUP INC.$CME | 74.5#157 | $1.0B | 3,484,020 |
 Planet Labs PBC$PL | 42.2#1,857 | $985.2M | 35,248,893 |
 AST SpaceMobile, Inc.$ASTS | 29.6#2,395 | $741.1M | 8,943,486 |
 Revolution Medicines, Inc.$RVMD | — | $320.2M | 3,292,525 |
 ARM HOLDINGS PLC /UK$ARM | — | $296.6M | 1,960,784 |
 Freshworks Inc.$FRSH | 55.5 | $130.1M | 16,206,643 |
 UiPath, Inc.$PATH | 67.7 | $78.1M | 7,034,337 |
 Tempus AI, Inc.$TEM | 38.2 | $70.1M | 1,551,102 |
 PayPay Corp$PAYP | — | $66.7M | 3,125,000 |
 Gitlab Inc.$GTLB | 54.1 | $59.0M | 2,724,712 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Alphabet Inc.'s 26 positions.
Showing top 10 of 26 holdings.
Sector Allocation
Technology
$1.6B
Financials
$1.1B
Communication Services
$741.1M
Healthcare
$512.9M
Industrials
$66.7M
Full Holdings — Alphabet Inc. (Q1 2026)
All 26 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $CME | CME GROUP INC. | $1.0B | 25.6% | NEW | 74.5 |
| 2 | $PL | Planet Labs PBC | $985.2M | 24.5% | +10% | 42.2 |
| 3 | $ASTS | AST SpaceMobile, Inc. | $741.1M | 18.5% | +0% | 29.6 |
| 4 | $RVMD | Revolution Medicines, Inc. | $320.2M | 8.0% | -2% | — |
| 5 | $ARM | ARM HOLDINGS PLC /UK | $296.6M | 7.4% | +0% | — |
| 6 | $FRSH | Freshworks Inc. | $130.1M | 3.2% | +0% | 55.5 |
| 7 | $PATH | UiPath, Inc. | $78.1M | 1.9% | +0% | 67.7 |
| 8 | $TEM | Tempus AI, Inc. | $70.1M | 1.8% | +0% | 38.2 |
| 9 | $PAYP | PayPay Corp | $66.7M | 1.7% | NEW | — |
| 10 | $GTLB | Gitlab Inc. | $59.0M | 1.5% | +0% | 54.1 |
| 11 |  $PRME | Prime Medicine, Inc. | $57.6M | 1.4% | +0% | 11.2 |
| 12 |  $LIFE | Ethos Technologies Inc. | $42.1M | 1.1% | NEW | — |
| 13 |  $MAZE | Maze Therapeutics, Inc. | $41.4M | 1.0% | +0% | 19.7 |
| 14 |  $BBOT | BridgeBio Oncology Therapeutics, Inc. | $25.3M | 0.6% | +0% | — |
| 15 |  $RLAY | Relay Therapeutics, Inc. | $15.6M | 0.4% | -0% | 12.7 |
| 16 |  $GLUE | Monte Rosa Therapeutics, Inc. | $11.3M | 0.3% | -8% | 18.1 |
| 17 |  $VERA | Vera Therapeutics, Inc. | $9.7M | 0.2% | +0% | — |
| 18 |  $SANA | Sana Biotechnology, Inc. | $8.1M | 0.2% | +0% | — |
| 19 |  $BEAM | Beam Therapeutics Inc. | $7.7M | 0.2% | +0% | 12.1 |
| 20 |  $LYEL | Lyell Immunopharma, Inc. | $5.9M | 0.1% | +0% | 3.6 |
| 21 |  $OSCR | Oscar Health, Inc. | $5.5M | 0.1% | +0% | 70.4 |
| 22 |  $FIG | Figma, Inc. | $4.6M | 0.1% | +0% | 45.2 |
| 23 |  $SPRO | Spero Therapeutics, Inc. | $2.1M | 0.1% | +0% | 19.5 |
| 24 |  $HYPR | Hyperfine, Inc. | $970,618 | 0.0% | +0% | — |
| 25 |  $AUTL | Autolus Therapeutics plc | $963,602 | 0.0% | +0% | — |
| 26 |  $TNYA | Tenaya Therapeutics, Inc. | $631,836 | 0.0% | +0% | — |
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Alphabet Inc. including:
Track Alphabet Inc.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Alphabet Inc. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Alphabet Inc.
13F Pro is an AI hedge fund tracker and stock research platform. For Alphabet Inc. (SEC CIK: 1652044), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Alphabet Inc.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.